Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers

被引:80
作者
Bradbury, Angela R. [1 ,2 ,3 ]
Ibe, Comfort. N. [2 ,3 ]
Dignam, James J. [4 ]
Cummings, Shelly A. [2 ,3 ]
Verp, Marion [2 ,5 ]
White, Melody A. [2 ,3 ]
Artioli, Grazia [6 ]
Dudlicek, Laura [2 ,3 ]
Olopade, Olufunmilayo L. [2 ,3 ]
机构
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[2] Univ Chicago, Ctr Clin Canc Genet, Chicago, IL 60637 USA
[3] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA
[4] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA
[5] Univ Chicago, Dept Obstet & Gynecol, Chicago, IL 60637 USA
[6] Inst Oncol Veneto, Padua, Italy
关键词
BRCA1; BRCA2; prophylactic salpingo-oophorectomy;
D O I
10.1097/GIM.0b013e318163487d
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose: To evaluate prophylactic salpingo-oophorectomy uptake and timing among BRCA1/2 mutation carriers in a cancer risk assessment program. Methods: Clinical records of female BRCA1/2 mutation carriers who received cancer genetic counseling between 1996 and 2003 were reviewed to determine the completion and the timing of prophylactic salpingo-oophorectomy, Logistic regression models evaluated associations between subject characteristics and surgery. Survival analysis methods were used to estimate the distribution of time to surgery. Results: Among 88 women, 70% underwent prophylactic salpingo-oophorectomy. Prophylactic salpingo-oophorectomy was associated with older age, white race, having children, and a family history of ovarian cancer. Many women waited more than 12 months to undergo surgery and some delayed by several years. Younger age and not having children were associated with delays to surgery. Conclusion: Prophylactic salpingo-ooporectomy is an acceptable risk reduction measure for many BRCA1/2 mutation carriers. Some women make this decision many years after genetic testing. Continued discussion of the risks and benefits of risk reduction options may facilitate the uptake of recommended risk reduction interventions among BRCA mutation carriers.
引用
收藏
页码:161 / 166
页数:6
相关论文
共 37 条
[1]  
American Cancer Society, 2006, CANC FACTS FIG 2007
[2]  
[Anonymous], 2003, Techniques for censored and truncated data, DOI DOI 10.1007/0-387-21645-6_3
[3]   Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies [J].
Antoniou, A ;
Pharoah, PDP ;
Narod, S ;
Risch, HA ;
Eyfjord, JE ;
Hopper, JL ;
Loman, N ;
Olsson, H ;
Johannsson, O ;
Borg, Å ;
Pasini, B ;
Radice, P ;
Manoukian, S ;
Eccles, DM ;
Tang, N ;
Olah, E ;
Anton-Culver, H ;
Warner, E ;
Lubinski, J ;
Gronwald, J ;
Gorski, B ;
Tulinius, H ;
Thorlacius, S ;
Eerola, H ;
Nevanlinna, H ;
Syrjäkoski, K ;
Kallioniemi, OP ;
Thompson, D ;
Evans, C ;
Peto, J ;
Lalloo, F ;
Evans, DG ;
Easton, DF .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1117-1130
[4]   Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer [J].
Armstrong, K ;
Micco, E ;
Carney, A ;
Stopfer, J ;
Putt, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (14) :1729-1736
[5]   Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations:: A decision analysis [J].
Armstrong, K ;
Schwartz, JS ;
Randall, T ;
Rubin, SC ;
Weber, B .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (06) :1045-1054
[6]  
Babb Sheri A, 2002, J Genet Couns, V11, P81, DOI 10.1023/A:1014571420844
[7]   Genetic testing for a BRCA1 mutation:: Prophylactic surgery and screening behavior in women 2 years post testing [J].
Botkin, JR ;
Smith, KR ;
Croyle, RT ;
Baty, BJ ;
Wylie, JE ;
Dutson, D ;
Chan, A ;
Hamann, HA ;
Lerman, C ;
McDonald, J ;
Venne, V ;
Ward, JH ;
Lyon, E .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2003, 118A (03) :201-209
[8]   Recommendations for follow-up care of individuals with an inherited predisposition to cancer .2. BRCA1 and BRCA2 [J].
Burke, W ;
Daly, M ;
Garber, J ;
Botkin, J ;
Kahn, MJE ;
Lynch, P ;
McTierman, A ;
Offit, K ;
Perlman, J ;
Petersen, G ;
Thomson, E ;
Varricchio, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (12) :997-1003
[9]   Surveillance behavior and prophylactic surgery after predictive testing for hereditary breast/ovarian cancer [J].
Claes, E ;
Evers-Kiebooms, G ;
Decruyenaere, M ;
Denayer, L ;
Boogaerts, A ;
Philippe, K ;
Legius, E .
BEHAVIORAL MEDICINE, 2005, 31 (03) :93-105
[10]  
EASTON DF, 1995, AM J HUM GENET, V56, P265